High quality raw material for IVD manufacturing industry

Recombinant antigen EBNA1 for Epstein-barr virus

RekomBiotech
Epstein-barr virus

EBNA1 has a predominant role in the maintenance of latent EBV infections and is expressed in all EBV infections and all EBV-associated malignant tissues. It contains a Gly-Ala repeated domain flanked by two unique regions. The central , C-terminus and N-terminus regions have been described as potentially antigenic.

View more information about Epstein-Barr virus infection.

REFERENCES
RAG0007 WB, DB, Indirect ELISA, positive control in direct ELISA, CLIA, lateral-flow
RAG0047 WB, DB, Indirect ELISA, positive control in direct ELISA
GENE
BKRF1
DESCRIPTION
Late nuclear antigen
PURITY
>95% in a SDS-PAGE
SHIPPING AND STORAGE CONDITIONS
Proteins will be shipped with dry ice or lyophilized. Upon arrival (if liquid), or after reconstitution (if lyophilized), they should be stored at -20ºC to -80ºC. Avoid multiple freeze/thaw cycles
STABILITY
The protein will remain stable for four years if stored frozen
SPECIFICITY
The protein is immunoreactive against seropositive individuals to Epstein-Barr virus infection
IVD
Serodiagnosis of infectious mononucleosis associated to EBV and primary acute infections in immunocompromised individuals
Best seller (Satisfaction guarantee)
EVALUATION
Optimization of the recombinant EBV nuclear antigen quality by improving its integrity in Escherichia Coli
PROMOTIONAL MATERIAL
Catalogue
Rekom EBV high quality raw material
Rekom Biotech Best sellers (Satisfaction guarantee)
Recombinant antigen EBNA1 for Epstein-barr virus
RELATED PRODUCTS
p138, p18, p23, p54, ZEBRA

FOR RESEARCH AND COMERCIAL USE IVD ONLY (*)

(*) Our antigens are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. For more information about the general features of our antigens, you can visit here.

RETURN TO HUMAN RECOMBINANT ANTIGENS